chr2-20670583-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_182828.4(GDF7):c.511C>T(p.Pro171Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000414 in 1,450,458 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_182828.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GDF7 | NM_182828.4 | c.511C>T | p.Pro171Ser | missense_variant | 2/2 | ENST00000272224.5 | NP_878248.2 | |
GDF7 | XM_047443522.1 | c.-138C>T | 5_prime_UTR_variant | 2/2 | XP_047299478.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GDF7 | ENST00000272224.5 | c.511C>T | p.Pro171Ser | missense_variant | 2/2 | 1 | NM_182828.4 | ENSP00000272224.3 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD3 exomes AF: 0.0000222 AC: 5AN: 225062Hom.: 0 AF XY: 0.0000243 AC XY: 3AN XY: 123250
GnomAD4 exome AF: 0.00000414 AC: 6AN: 1450458Hom.: 0 Cov.: 30 AF XY: 0.00000416 AC XY: 3AN XY: 720978
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.511C>T (p.P171S) alteration is located in exon 2 (coding exon 2) of the GDF7 gene. This alteration results from a C to T substitution at nucleotide position 511, causing the proline (P) at amino acid position 171 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at